Kinoxis Therapeutics PTY LTD

Camberwell, VIC

UEI
GSKYRUM72Q53
CAGE
Z12K0
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
International Organization
SAM.gov registration date
Physical address
Suite 201/697 Burke Rd, Camberwell VIC 3124, Australia

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Advancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical… UH3DA048743 National Institute on Drug Abuse (NIH) $3,603,973
Advancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical… UG3DA048743 National Institute on Drug Abuse (NIH) $2,792,900

Quick answers

Is Kinoxis Therapeutics PTY LTD registered in SAM.gov?

Yes. Kinoxis Therapeutics PTY LTD's SAM.gov registration is active through January 18, 2027.

What is Kinoxis Therapeutics PTY LTD's most recent federal award?

Kinoxis Therapeutics PTY LTD's most recent federal grant award is Advancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical… (UH3DA048743), from National Institute on Drug Abuse (NIH), on September 30, 2019.

On GovTribe

See Kinoxis Therapeutics PTY LTD's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login